Cargando…
Suggested risk factor for oral lichen planus arising after mRNA COVID‐19 vaccination
A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307884/ https://www.ncbi.nlm.nih.gov/pubmed/35898746 http://dx.doi.org/10.1002/ccr3.6126 |
| Sumario: | A single dose of BNT162b2 vaccine is suggested for COVID‐19‐infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP). |
|---|